475 related articles for article (PubMed ID: 17521857)
1. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
[TBL] [Abstract][Full Text] [Related]
2. [Non-HFE-related hereditary iron overload].
Aguilar-Martinez P
Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
[TBL] [Abstract][Full Text] [Related]
3. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
4. Hemochromatosis: genetics and pathophysiology.
Beutler E
Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
[TBL] [Abstract][Full Text] [Related]
5. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
[TBL] [Abstract][Full Text] [Related]
6. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
[TBL] [Abstract][Full Text] [Related]
7. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
[TBL] [Abstract][Full Text] [Related]
9. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
[TBL] [Abstract][Full Text] [Related]
10. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
[TBL] [Abstract][Full Text] [Related]
11. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
12. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.
Roetto A; Camaschella C
Best Pract Res Clin Haematol; 2005 Jun; 18(2):235-50. PubMed ID: 15737887
[TBL] [Abstract][Full Text] [Related]
13. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
[TBL] [Abstract][Full Text] [Related]
14. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
15. Protective role of calreticulin in HFE hemochromatosis.
Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
[TBL] [Abstract][Full Text] [Related]
16. The molecular pathogenesis of hereditary hemochromatosis.
Babitt JL; Lin HY
Semin Liver Dis; 2011 Aug; 31(3):280-92. PubMed ID: 21901658
[TBL] [Abstract][Full Text] [Related]
17. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
[TBL] [Abstract][Full Text] [Related]
18. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M
Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511
[TBL] [Abstract][Full Text] [Related]
19. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.
D'Alessio F; Hentze MW; Muckenthaler MU
J Hepatol; 2012 Nov; 57(5):1052-60. PubMed ID: 22728873
[TBL] [Abstract][Full Text] [Related]
20. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
